• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

China: Coronavirus: recovered Chinese patients may be defenceless against foreign mutation, study says

Commonground

Senior Moderator
21 Jun, 2020
Excerpts:
  • Antibodies found in blood of people who have fought disease failed to stop D614G, Chinese scientists say
  • Mutant form identified in genetic data of samples collected at Xinfadi food market in Beijing where latest outbreak began
-snip-
Since the latest coronavirus outbreak was reported at the Xinfadi wholesale food market in Beijing, 227 new infections have been confirmed and more than 2.3 million residents have been tested for Covid-19 in a bid to contain the spread.

Health authorities identified the infection in a number of locations at the market, including inside the mouths of imported salmon. The whole genome sequencing data of samples from the first three patients have been released and they all contained the D614G mutation.
-snip-
In the Chongqing study, the antibodies generated by three patients failed to suppress the mutated strain, with one sample showing almost zero effect.

The researchers then tried to infect host cells with the mutant and normal strains. The mutant’s entry efficiency was 2.4 times higher.
-snip-
“Given the evolving nature of the SARS-CoV-2 RNA genome, antibody treatment and vaccine design might require further consideration to accommodate the D614G and other mutations that may affect the immunogenicity of the virus,” Huang said.

About 10 per cent of the people infected by the new outbreak in Beijing are in a critical condition, according to the city’s health authorities, and medical teams from across the country have been flown into to help with the aid effort.

https://www.scmp.com/coronavirus/gre...be-defenceless
 
Back
Top